Ex Vivo Pharmacokinetic/Pharmacodynamic Integration Model of Cefquinome Against <i>Escherichia coli</i> in Foals

Cefquinome is used to treat septicemia caused by <i>Escherichia coli</i> (<i>E. coli</i>) and respiratory infections caused by <i>Streptococcus equi</i> subsp. <i>zooepidemicus</i> in foals. However, studies reporting the use of cefquinome to target &l...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Veterinary Sciences
المؤلفون الرئيسيون:	Tiantian Gao, Xuesong Liu, Di Qiu, Yanan Li, Zongsheng Qiu, Jingjing Qi, Shuxin Li, Xiaoyan Guo, Yan Zhang, Ziqi Wang, Xiang Gao, Yuhui Ma, Tianwen Ma
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2025-03-01
الموضوعات:	cefquinome <i>Escherichia coli</i> PK/PD model dose regimen
الوصول للمادة أونلاين:	https://www.mdpi.com/2306-7381/12/4/294

مواد مشابهة

Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals
حسب: Dong-Ha Lee, وآخرون
منشور في: (2020-10-01)

Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome against Experimental Catheter-associated Biofilm Infection due to Staphylococcus aureus
حسب: Yu-Feng eZhou, وآخرون
منشور في: (2016-01-01)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
حسب: Longfei Zhang, وآخرون
منشور في: (2020-08-01)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
حسب: Ijaz eAhmad, وآخرون
منشور في: (2015-06-01)

Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an in vitro Model
حسب: Yafei eLi, وآخرون
منشور في: (2016-04-01)

Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China
حسب: Kun Mi, وآخرون
منشور في: (2021-01-01)

Adaptive Resistance of <i>Staphylococcus aureus</i> to Cefquinome Sulfate in an In Vitro Pharmacokinetic Model with Transcriptomic Insights
حسب: Yue Hu, وآخرون
منشور في: (2025-02-01)

PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model
حسب: Yanzhe Wei, وآخرون
منشور في: (2023-10-01)

Effect of Meloxicam on the Pharmacokinetics of Cefquinome in Endotoxemic Sheep
حسب: Muhittin Uslu, وآخرون
منشور في: (2025-09-01)

Lung microdialysis and in vivo PK/PD integration of cefquinome against Actinobacillus pleuropneumoniae in a porcine experimental lung infection model
حسب: Yuqin Chen, وآخرون
منشور في: (2024-03-01)

Microdialysis Determination of Cefquinome Pharmacokinetics in Murine Thigh From Healthy, Neutropenic, and Actinobacillus pleuropneumoniae-Infected Mice
حسب: Longfei Zhang, وآخرون
منشور في: (2019-03-01)

Determination of Susceptibility Breakpoint for Cefquinome against <i>Streptococcus suis</i> in Pigs
حسب: Kun Mi, وآخرون
منشور في: (2021-08-01)

Disposition of Cefquinome in Turkeys (<i>Meleagris gallopavo</i>) Following Intravenous and Intramuscular Administration
حسب: Mohamed Elbadawy, وآخرون
منشور في: (2021-10-01)

Environmental fate of cefquinome: Adsorption and degradation
حسب: Jicheng Qiu, وآخرون
منشور في: (2022-10-01)

Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus)
حسب: Dong-Hao Zhao, وآخرون
منشور في: (2017-07-01)

Pharmacokinetics and Residues of Cefquinome in Milk of Lactating Chinese Dairy Cows After Intramammary Administration
حسب: Ya-fei LI, وآخرون
منشور في: (2014-12-01)

Histidine Metabolism and IGPD Play a Key Role in Cefquinome Inhibiting Biofilm Formation of Staphylococcus xylosus
حسب: Yong-hui Zhou, وآخرون
منشور في: (2018-04-01)

Susceptibility breakpoint for cefquinome against Escherichia coli and Staphylococcus aureus from pigs
حسب: Hui-lin ZHANG, وآخرون
منشور في: (2021-07-01)

Pharmacokinetics and relative bioavailability study of two cefquinome sulfate intramammary infusions in cow milk
حسب: Shuang Li, وآخرون
منشور في: (2024-03-01)

Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs
حسب: Lingli Huang, وآخرون
منشور في: (2018-10-01)

Migration of Cefquinome Antibiotic Residues from Milk to Dairy Products
حسب: Melissa Di Rocco, وآخرون
منشور في: (2021-11-01)

Application of Semi-Mechanistic Pharmacokinetic and Pharmacodynamic Model in Antimicrobial Resistance
حسب: Kun Mi, وآخرون
منشور في: (2022-01-01)

A methodological review on the pharmacokinetic/pharmacodynamic integration of antibacterial drugs
حسب: Hongjuan WANG, وآخرون
منشور في: (2022-02-01)

Elimination of Cefquinome Sulfate Residue in Cow’s Milk after Intrauterine Infusion
حسب: Chunshuang Liu, وآخرون
منشور في: (2023-03-01)

Gastric Acid-Protective and Intestinal Targeted Nanogels Enable Anti-Bacterial Activity of Cefquinome
حسب: Xianqiang Li, وآخرون
منشور في: (2025-06-01)

Pharmacokinetic–Pharmacodynamic Correlation Analysis of <i>Rhodiola crenulata</i> in Rats with Myocardial Ischemia
حسب: Zhixin Jia, وآخرون
منشور في: (2024-05-01)

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant <i>Staphylococcus aureus</i>
حسب: Katharina Rox, وآخرون
منشور في: (2022-12-01)

Preparation and testing of cefquinome-loaded poly lactic-co-glycolic acid microspheres for lung targeting
حسب: Shaoqi Qu, وآخرون
منشور في: (2017-01-01)

Optimizing Antibiotic Therapy for <i>Stenotrophomonas maltophilia</i> Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach
حسب: Helena Barrasa, وآخرون
منشور في: (2024-06-01)

Determination of Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Parameters of Doxycycline against <i>Edwardsiella ictaluri</i> in Yellow Catfish (<i>Pelteobagrus fulvidraco</i>)
حسب: Ning Xu, وآخرون
منشور في: (2021-03-01)

In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against <i>Candida auris</i>
حسب: Unai Caballero, وآخرون
منشور في: (2021-10-01)

PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against <i>Streptococcus suis</i> in Piglets
حسب: Anxiong Huang, وآخرون
منشور في: (2022-02-01)

The dose regimen formulation of doxycycline hydrochloride and florfenicol injection based on ex vivo pharmacokinetic-pharmacodynamic modeling against the Actinobacillus pleuropneumoniae in pigs
حسب: Yuanyuan Yuan, وآخرون
منشور في: (2023-02-01)

Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Methods for the Quantification of Cefquinome, Ceftiofur, and Desfuroylceftiofuracetamide in Porcine Feces with Emphasis on Analyte Stability
حسب: Sofie Rutjens, وآخرون
منشور في: (2021-07-01)

Using Pharmacokinetic–Pharmacodynamic Modeling to Study the Main Active Substances of the Anticancer Effect in Mice from <i>Panax ginseng</i>–<i>Ophiopogon japonicus</i>
حسب: Lu Liu, وآخرون
منشور في: (2024-01-01)

In vivo pharmacokinetic and pharmacodynamic profiles of orbifloxacin against Staphylococcus aureus in a neutropenic murine thigh infection model
حسب: Long-Gen Zhong, وآخرون
منشور في: (2025-08-01)

In vivo pharmacokinetic and pharmacodynamic study and cutoff of florfenicol against Riemerella anatipestifer in ducks
حسب: Hui-Lin Zhang, وآخرون
منشور في: (2025-01-01)

Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against <i>Staphylococcus pseudintermedius</i> in Dogs
حسب: Ji-Soo Jeong, وآخرون
منشور في: (2024-12-01)

Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
حسب: Xin-Yi Wei, وآخرون
منشور في: (2024-04-01)

Rutin and <i>Physalis peruviana</i> Extract: Population Pharmacokinetics in New Zealand Rabbits
حسب: Gina Paola Domínguez Moré, وآخرون
منشور في: (2024-09-01)